跳至主要内容
临床试验/NCT03614962
NCT03614962招募中不适用

Efficacy of Warmth and Transcutaneous Electrical Nerve Stimulation (TENS) in Improving Cognitive Functions and Behavioral Symptoms in Older Adults with Dementia: a Randomized, Controlled Clinical Trial

The Hong Kong Polytechnic University1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2019年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
150
试验地点
1
主要终点
The Hong Kong version of Montreal Cognitive Assessment (HK-MoCA) - Baseline

研究概览

简要总结

Evidence showed that both TENS and passive body heating are potential treatment strategies for improving cognitive functions in people with dementia. It is hypothesized that hat device (Warmth +TENS) over the 4 acupuncture points would induce a greater improvement in cognitive functions and behavioural symptoms when compared with other hat devices (Warmth + placebo-TENS; TENS only; Warmth alone) and Control (hat device with no warmth and no TENS).

详细描述

Acupuncture, a primary therapeutic method in traditional Chinese medicine, has been used for patients with dementia to improve memory, orientation, calculation, and self-managing ability in patients having dementia and prevent decline of cognitive functions. Results of animal studies have demonstrated that electroacupuncture on the head region is effective in managing the symptoms associated with dementia, including vascular dementia.

A review of 8 studies on effects of TENS on non-pain related cognitive and behavioural functioning in patients with Alzheimer's disease and non-demented patients concluded that TENS could improve memory, affective behaviour and rest-activity rhythm in patients having Alzheimer's disease.

Passive body heating is another novel physical intervention strategy which potentially can relieve the symptoms of dementia. A previous study demonstrated that the attention function of 15 elderly, measured by the reaction time in the Rapid Visual Processing Test, improved after passive body heating via a thermal suit. Moreover, 30 minutes of hot-water immersion improved the sleep quality in 13 people with vascular dementia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • are currently diagnosed having Alzheimer's disease, vascular dementia or mixed-type mild to major neurocognitive disorder based on the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM -5) by psychogeriatrician with more than 3 years of experience in dementia diagnosis;
  • are categorized in the mild or moderate degree of dementia based on the Global Deterioration Scale;
  • have a stable drug intake for the past 3 months;
  • live with at least 1 caregiver in the community;
  • are able to follow simple instructions;
  • are able to give informed consent by them or their family members.

排除标准

  • have unstable medical conditions or severe behavioural disturbances, which do not allow participation in the study as judged by the study psychogeriatrician,
  • have any additional medical, cardiovascular , orthopedic or cognitive conditions, such as having uncontrolled hypertension unstable angina and comorbid schizophrenia, that would hinder proper assessment and treatment.
  • use a cardiac pacemaker,
  • live in old age home, elderly home or care and attention homes,
  • receive long term nursing home placements of patients during the treatment phase

结局指标

主要结局

The Hong Kong version of Montreal Cognitive Assessment (HK-MoCA) - Baseline

时间窗: Baseline (0 week)

The HK-MoCA will be used to assess the level of cognitive impairment. The scores of HK-MoCA ranging from 0 to 30, with a higher score indicates a higher level of cognitive function. This instrument was designed to evaluate 7 domains of cognitive functions which are key determinants of the functional performance of the participants, namely visuospatial/executive functions, naming, verbal memory registration and learning, attention, abstraction, delayed verbal memory.

The Hong Kong version of Montreal Cognitive Assessment (HK-MoCA) - post intervention

时间窗: 6 weeks

The HK-MoCA will be used to assess the level of cognitive impairment. The scores of HK-MoCA ranging from 0 to 30, with a higher score indicates a higher level of cognitive function. This instrument was designed to evaluate 7 domains of cognitive functions which are key determinants of the functional performance of the participants, namely visuospatial/executive functions, naming, verbal memory registration and learning, attention, abstraction, delayed verbal memory.

The Hong Kong version of Montreal Cognitive Assessment (HK-MoCA) - short term followup

时间窗: 10 weeks

The HK-MoCA will be used to assess the level of cognitive impairment. The scores of HK-MoCA ranging from 0 to 30, with a higher score indicates a higher level of cognitive function. This instrument was designed to evaluate 7 domains of cognitive functions which are key determinants of the functional performance of the participants, namely visuospatial/executive functions, naming, verbal memory registration and learning, attention, abstraction, delayed verbal memory.

The Hong Kong version of Montreal Cognitive Assessment (HK-MoCA) - long term followup

时间窗: 62 weeks

The HK-MoCA will be used to assess the level of cognitive impairment. The scores of HK-MoCA ranging from 0 to 30, with a higher score indicates a higher level of cognitive function. This instrument was designed to evaluate 7 domains of cognitive functions which are key determinants of the functional performance of the participants, namely visuospatial/executive functions, naming, verbal memory registration and learning, attention, abstraction, delayed verbal memory.

次要结局

  • Chinese version of Disability Assessment for Dementia (C-DAD) - long term followup(62 weeks)
  • Chinese version of Disability Assessment for Dementia (C-DAD) - baseline(baseline (0 week))
  • Chinese version of Disability Assessment for Dementia (C-DAD) - post intervention(6 weeks)
  • Chinese version of Disability Assessment for Dementia (C-DAD) - short term followup(10 weeks)
  • Pittsburg Sleep Quality Index (PSQI) - post intervention(6 weeks)
  • Pittsburg Sleep Quality Index (PSQI) - baseline(baseline (0 weeks))
  • Pittsburg Sleep Quality Index (PSQI) - short term followup(10 weeks)
  • Pittsburg Sleep Quality Index (PSQI) - long term followup(62 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shamay Ng

Associate Professor

The Hong Kong Polytechnic University

研究点 (1)

Loading locations...

相似试验

Warmth and Transcutaneous Electrical Nerve... | 临床试验